glutamic acid has been researched along with benzoxazoles in 14 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (28.57) | 29.6817 |
| 2010's | 9 (64.29) | 24.3611 |
| 2020's | 1 (7.14) | 2.80 |
| Authors | Studies |
|---|---|
| Hernández, JV; Mateos, AA; Morán, JR; Muñiz, FM; Oliva, AI; Simón, L | 1 |
| Bédard, PJ; Bélanger, N; Darré, A; Grégoire, L; Hadj Tahar, A; Meltzer, L | 1 |
| Hara, H; Morimoto, N; Nagai, H; Shimazawa, M; Yamashima, T | 1 |
| Chou, YC; Huang, WC; Lee, WL; Lo, JC; Sun, SH; Tseng, CH | 1 |
| Chen, MC; Liu, YP; Sun, SH; Tzeng, SF; Yang, CS | 1 |
| Bates, BS; Chauder, BA; Conn, PJ; Dawson, ES; Emmitte, KA; Felts, AS; Gregory, KJ; Jadhav, SB; Jones, CK; Kane, AS; Lamb, JP; Lindsley, CW; Meiler, J; Menon, UN; Mueller, R; Niswender, CM; Olsen, CM; Rodriguez, AL; Winder, DG | 1 |
| Aston-Jones, G; Mahler, SV; Smith, RJ | 1 |
| Amadeo, A; Aracri, P; Banfi, D; Becchetti, A; Pasini, ME | 1 |
| Acker, T; Haverkamp, T; Kimmich, C; Krämer, HH; Röcken, C; Schänzer, A; Weidner, I | 1 |
| Elahdadi Salmani, M; Goudarzi, E; Goudarzi, I; Lashkarbolouki, T | 1 |
| Crommen, J; Han, H; Jiang, Z; Peng, K; Ruan, M; Wang, Q; Wu, H; Zhu, P | 1 |
| Azizi, H; Hooshmand, B; Javan, M; Semnanian, S | 1 |
| Boccella, S; de Novellis, V; Farina, A; Guida, F; Iannotta, M; Luongo, L; Maione, S; Marabese, I; Palazzo, E; Serra, N | 1 |
| Bdir, S; Hawash, M; Nacak Baytas, S; Qneibi, M | 1 |
14 other study(ies) available for glutamic acid and benzoxazoles
| Article | Year |
|---|---|
Enantioselective chromenone benzoxazole receptor for glutamic acid and its derivatives.
Topics: Benzoxazoles; Dansyl Compounds; Glutamates; Glutamic Acid; Models, Molecular; Molecular Mimicry; Molecular Structure; Receptors, Glutamate; Stereoisomerism | 2003 |
Effect of a selective glutamate antagonist on L-dopa-induced dyskinesias in drug-naive parkinsonian monkeys.
Topics: Animals; Benzoxazoles; Corpus Striatum; Disease Models, Animal; Drug Interactions; Dyskinesia, Drug-Induced; Excitatory Amino Acid Antagonists; Female; Glutamic Acid; Levodopa; Macaca fascicularis; Parkinson Disease; Piperidines; Receptors, N-Methyl-D-Aspartate; Treatment Outcome | 2004 |
Minocycline inhibits oxidative stress and decreases in vitro and in vivo ischemic neuronal damage.
Topics: Animals; Antioxidants; Benzimidazoles; Benzoxazoles; Biphenyl Compounds; Brain Edema; Brain Infarction; Cell Death; Cell Survival; Cells, Cultured; Cerebral Cortex; Chromans; Dose-Response Relationship, Drug; Drug Interactions; Embryo, Mammalian; Fluorescent Dyes; Glutamic Acid; Hydrazines; Infarction, Middle Cerebral Artery; Inhibitory Concentration 50; Ischemia; Lipid Peroxidation; Male; Mice; Minocycline; Neurons; Neuroprotective Agents; Oxidative Stress; Picrates; Quinolinium Compounds; Saponins; Tetrazolium Salts; Time Factors | 2005 |
Activation of P2X(7) receptors decreases glutamate uptake and glutamine synthetase activity in RBA-2 astrocytes via distinct mechanisms.
Topics: Adenosine Triphosphate; Amino Acid Transport System X-AG; Animals; Animals, Newborn; Astrocytes; Benzoxazoles; Calcium; Cells, Cultured; Cerebral Cortex; Drug Interactions; Enzyme Inhibitors; Glutamate-Ammonia Ligase; Glutamic Acid; Quinolinium Compounds; Rats; Receptors, Purinergic P2; Receptors, Purinergic P2X7 | 2008 |
Ca(2+)-dependent reduction of glutamate aspartate transporter GLAST expression in astrocytes by P2X(7) receptor-mediated phosphoinositide 3-kinase signaling.
Topics: Adenosine Triphosphate; Animals; Animals, Newborn; Aspartic Acid; Astrocytes; Benzoxazoles; Calcium; Cells, Cultured; Disease Models, Animal; Enzyme Inhibitors; Excitatory Amino Acid Transporter 1; Female; Gene Expression Regulation; Glutamic Acid; Humans; Injections, Spinal; Neurons; Phosphatidylinositol 3-Kinases; Platelet Aggregation Inhibitors; Purinergic P2 Receptor Agonists; Purinergic P2 Receptor Antagonists; Pyridoxal Phosphate; Quinolinium Compounds; Rats; Rats, Sprague-Dawley; Receptors, Purinergic P2; Receptors, Purinergic P2X7; RNA, Messenger; RNA, Small Interfering; Signal Transduction; Spinal Cord Injuries; Transfection | 2010 |
Discovery of 2-(2-benzoxazoyl amino)-4-aryl-5-cyanopyrimidine as negative allosteric modulators (NAMs) of metabotropic glutamate receptor 5 (mGlu₅): from an artificial neural network virtual screen to an in vivo tool compound.
Topics: Allosteric Regulation; Animals; Anxiety Disorders; Behavior, Animal; Benzoxazoles; Brain; Drug Discovery; Glutamic Acid; HEK293 Cells; High-Throughput Screening Assays; Humans; Injections, Intraperitoneal; Mice; Mice, Inbred C57BL; Neural Networks, Computer; Psychotropic Drugs; Pyrimidines; Receptor, Metabotropic Glutamate 5; Receptors, Metabotropic Glutamate; ROC Curve; Small Molecule Libraries | 2012 |
Interactions between VTA orexin and glutamate in cue-induced reinstatement of cocaine seeking in rats.
Topics: 2-Amino-5-phosphonovalerate; 6-Cyano-7-nitroquinoxaline-2,3-dione; Animals; Benzoxazoles; Cocaine; Cues; Dose-Response Relationship, Drug; Drug-Seeking Behavior; Glutamic Acid; Intracellular Signaling Peptides and Proteins; Male; Naphthyridines; Neuropeptides; Orexin Receptors; Orexins; Rats; Rats, Sprague-Dawley; Receptors, AMPA; Receptors, G-Protein-Coupled; Receptors, N-Methyl-D-Aspartate; Receptors, Neuropeptide; Self Administration; Signal Transduction; Urea; Ventral Tegmental Area | 2013 |
Hypocretin (orexin) regulates glutamate input to fast-spiking interneurons in layer V of the Fr2 region of the murine prefrontal cortex.
Topics: Animals; Benzoxazoles; Electrophysiology; Excitatory Postsynaptic Potentials; Glutamic Acid; Inhibitory Postsynaptic Potentials; Interneurons; Mice; Mice, Inbred Strains; Naphthyridines; Neural Inhibition; Orexin Receptor Antagonists; Orexin Receptors; Orexins; Patch-Clamp Techniques; Prefrontal Cortex; Pyramidal Cells; Receptors, Ionotropic Glutamate; Synaptic Transmission; Tissue Culture Techniques; Urea; Vesicular Glutamate Transport Protein 1; Vesicular Glutamate Transport Protein 2 | 2015 |
A woman with a rare p.Glu74Gly transthyretin mutation presenting exclusively with a rapidly progressive neuropathy: a case report.
Topics: Adult; Amyloid Neuropathies, Familial; Benzoxazoles; Disease Progression; Fatal Outcome; Female; Genetic Linkage; Glutamic Acid; Glycine; Humans; Liver Transplantation; Mutation, Missense; Pedigree; Prealbumin | 2014 |
Hippocampal orexin receptors inactivation reduces PTZ induced seizures of male rats.
Topics: Animals; Benzoxazoles; Convulsants; gamma-Aminobutyric Acid; Glutamic Acid; Hippocampus; Isoquinolines; Male; Microinjections; Naphthyridines; Orexin Receptor Antagonists; Orexin Receptors; Pentylenetetrazole; Pyridines; Rats; Seizures; Urea | 2015 |
Enantioseparation of N-derivatized amino acids by micro-liquid chromatography/laser induced fluorescence detection using quinidine-based monolithic columns.
Topics: Amino Acids; Benzoxazoles; Chromatography, Liquid; Fluorescence; Glutamic Acid; Lasers; Methacrylates; Permeability; Quinidine; Reproducibility of Results; Stereoisomerism | 2016 |
Intra-LC microinjection of orexin type-1 receptor antagonist SB-334867 attenuates the expression of glutamate-induced opiate withdrawal like signs during the active phase in rats.
Topics: Animals; Benzoxazoles; Disease Models, Animal; Glutamic Acid; Locus Coeruleus; Male; Microinjections; Morphine; Naphthyridines; Orexin Receptor Antagonists; Orexins; Rats, Wistar; Substance Withdrawal Syndrome; Urea | 2017 |
Metabotropic glutamate receptor subtype 7 in the dorsal striatum oppositely modulates pain in sham and neuropathic rats.
Topics: Animals; Benzhydryl Compounds; Benzoxazoles; Corpus Striatum; Glutamic Acid; Hyperalgesia; Lidocaine; Male; Medulla Oblongata; Microinjections; Neuralgia; Neurons; Neuroprotective Agents; Pain; Rats; Receptors, Metabotropic Glutamate; Reticular Formation; Sciatic Nerve; Subthalamic Nucleus | 2018 |
Targeting the kinetics mechanism of AMPA receptor inhibition by 2-oxo-3H-benzoxazole derivatives.
Topics: alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid; Benzoxazoles; Glutamic Acid; HEK293 Cells; Humans; Receptors, AMPA | 2022 |